1 National University of Singapore Centre for Biomedical Ethics, Singapore 2 Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore Semaglutide, ...

The mum-of-three recently discovered that she's also been suffering from hair loss - which she jokingly said will make her look like ''Dr Evil ... listed in Mounjaro's package insert, a 2022 ...

Move over, chips and cookies – snacking is getting a GLP-1-era makeover. A recent Cornell University and Numerator study found households with at least one user of GLP-1 – medications like ...

A WOMAN has joked her partner will have to get used to seeing her bald head, following huge hair loss whilst on Mounjaro.

US pharma giant Eli Lilly's obesity management drug Mounjaro has now been launched in India. Interestingly, compared to the US, the price of Mounjaro in India will be one-fifth. Apart from obesity, ...

The dual action mechanism sets Mounjaro apart from older GLP-1 receptors like Ozempic (semaglutide)—potentially making it more effective for both blood sugar control and weight loss.

“He’s the best of us but doesn’t act like he’s better than any of us,” Simmons said. As they seek to rebuild — and in some ways, reinvent — their party, Democrats have been testing ...

Madonna, who earned the title "Queen of Pop" for her legendary music career, might be 66 years old, but she certainly did not look like it in some recent photos she shared on social media.

“Combine berberine with lifestyle changes, like losing weight, and it can positively affect those conditions.” The Cleveland Clinic also warns against buying into the “nature’s Ozempic ...

Ozempic is classified as glucagon-like peptide 1 (GLP-1), which mimics the hormone your body naturally makes that helps manage blood sugar and reduce appetite. GLP-1s don’t necessarily cause ...

New research suggests that drugs like Ozempic may provide more health benefits than previously thought. These medications, known as glucagon-like peptide-1 receptor agonists (GLP-1RAs), appear to ...